Stent Balloon Articles & Analysis
4 articles found
Alucent Biomedical Inc. is rethinking peripheral artery disease (PAD) treatment with a novel natural scaffolding technology based on a light-activated drug therapy delivered via a balloon catheter. This first-of-its-kind drug-device therapy, known as Natural Vascular Scaffolding (AlucentNVS), is designed to provide a more natural and effective way of establishing and maintaining ...
After pre-dilatation of SB with 2,5/12 mm NC balloon, Tryton stent 2.5/3.0 was deployed. Post dilatation with compliant 2.5/10mm balloon at 8 ...
Prior to the inception of Thrombolex, the most notable achievement was the development of the generations of specialty stents, which led to a transformational change in the endovascular treatment of obstructive lesions in the coronary, iliac, renal and carotid arteries. Some of these prior innovations that members of our leadership team were involved with include the ...
Proximally, at least one below-the-knee (BTK) vessel must be open (with or without previous angioplasty and/or stenting) to function as the inflow of the arterialization. The target inflow artery at the crossover point must be treatable with a 3.5- to 4-mm stent. ...